RARE β€” ULTRAGENYX PHARMACEUTICAL IN

Ownership history in Advisory Services Network, LLC  Β·  6 quarters on record

This page tracks every 13F SEC filing in which Advisory Services Network, LLC reported a position in ULTRAGENYX PHARMACEUTICAL IN (RARE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

Position Intelligence

Advisory Services Network, LLC Γ— RARE AI Analytics

πŸ“‰ Advisory Services Network, LLC underperformed the S&P 500 by –59.4% annually on this RARE position. Timing score: 100% (3/3 decisions correct). Average cost basis: $37.26. Maximum drawdown during holding period: –63.4%.

πŸ“ˆ Position Alpha vs SPY
-59.4%
annualised excess return

❌ Significantly underperformed the S&P 500 by 59.4% ann.
5 quarters analyzed

⏱️ Timing Score
100%

🎯 Smart timing β€” consistently buying dips and trimming near peaks.
3 of 3 add/trim decisions correct

πŸ’° Entry Quality
$37.26
-19.3% vs current ($30.08)

Best entry: $30.08 (2025 Q3)  Β·  Worst: $42.71 (2019 Q4)

πŸ›‘οΈ Drawdown Resilience
–63.4%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
50%
buy-side decisions

2 adds Β· 2 trims. Bought during 1 of 3 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    RARE price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 6 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 20 +19 +1900.0% 0.00% $602 $30.08
2023 Q4 UNCHANGED 1 β€” 0% 0.00% $48 $47.82
2023 Q1 UNCHANGED 1 β€” 0% 0.00% $40 $40.10
2022 Q4 REDUCED 1 -15 -93.8% 0.00% $46 $46.33
2020 Q3 REDUCED 16 -9 -36.0% 0.00% $1K $82.19
2019 Q4 INITIATED 25 β€” β€” 0.00% $1K $42.71

🏒 Other funds also holding RARE

As of 2025 Q4 β€” sorted by position size

GordonMD Global Investments LP 5.43% B Group, Inc. 2.29% GREAT POINT PARTNERS LLC 3Y 7Y 2.24% Stonepine Capital Management, LLC 3Y 7Y 1.68% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.56% Privium Fund Management B.V. 3Y 1.51% Rock Springs Capital Management LP 3Y 7Y 1.49% Palo Alto Investors LP 3Y 7Y 1.48% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.34% Krensavage Asset Management, LLC 3Y 7Y 1.22%
← Back to Advisory Services Network, LLC Holdings